North America

As part of the collaboration, UNC will use the firm's BarreGen assay to target molecular changes to predict resistance or relapse following ablation.

A federal court said Guardant CEO Helmy Eltoukhy deleted emails pertaining to two similar cases, but it remains unclear whether he did so intentionally.

Most diagnostics companies saw increases in share prices compared to last year, resulting in a significant jump in the 360Dx Index.

The company will use the proceeds to strengthen its balance sheet and support the commercial launch of new products and development activities over the coming year.

Gainers in the index outpaced the decliners 19 to nine, and the index outpaced the Dow Jones Industrial Average and Nasdaq Biotechnology Index but lagged the Nasdaq.

The LCD for the RNA gene expression test will take effect on Feb. 10, 2020, the Medicare contractor said.

The investment bank gave PerkinElmer an Outperform rating with a $114 stock price target and Hologic an In Line rating with a $55 stock price target.

The registry is designed to help pathology practices comply with requirements under Medicare’s Quality Payment Program and Merit-Based Incentive Payment System.